We've also talked about just the importance of people at the company need to scale together with it. I'm curious for you personally, what was that like for you? You know, how did you kind of navigate the challenges of it's so different at a young startup and just how fast and streamlined everything is versus, you know, the size of the organization that you're at today? Yeah, very good question because like these scaling and you know, making sure you're ready for next chapter actually first even gets out flight to the founders,. It starts from top and I tell you a couple of things really help me. One is I commented that always I want to have a mentor next to
This week, we’re super excited to have AmirAli Talasaz, co-CEO and co-founder of Guardant Health, a leading precision oncology company focused on helping conquer cancer globally.
Founded in 2011, Guardant Health is focused on helping conquer cancer through the use of its proprietary blood-based tests, vast data sets and advanced analytics. Guardant’s solutions include treatment selection, recurrence detection and early detection of cancer. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum.
Through multiple rounds of private financing, Guardant Health raised over $500 million from investors including Sequoia, Khosla, Lightspeed, OrbiMed, and Softbank, and Pear! and Guardant completed a successful IPO in October 2018.